News | SPECT-CT | October 18, 2022

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

October 18, 2022 —  Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore SPECT/CT configuration. This functionality is available in the new VERITON-CT 400 Series Digital SPECT/CT scanners, enabling total body, brain, heart and other imaging applications. 

“This truly represents a transformation in how we will image high energy isotopes: with the sensitivity benefits of digital detector technology, advanced reconstruction algorithms and total body coverage in 3D, both patients and clinicians will benefit from this innovation”, said Nathaniel Roth, VP Research and Development and Clinical Research, Spectrum Dynamics. 

The VERITON-CT 400 Series features Spectrum Dynamics’ radical design, with its 3600 ring-shaped gantry with 12 swiveling CZT detectors, that revolutionized nuclear medicine imaging industry in 2017. During the scan, the digital detectors automatically follow the patient’s body contour, providing exceptional proximity for increased sensitivity and better image quality. This design results in three times the volumetric sensitivity for routine 3D hybrid imaging without compromising patients comfort or department workflow. The scanner is available in 16-slice CT and 64-slice CT configuration enabling localization and attenuation correction for accurate quantification. 

“The new VERITON-CT 400 has proved to be advantageous for high-energy tracers. In our nuclear medicine community, the main challenge now is to personalize and adapt targeted treatments to each individual. This requires precise determination of the distribution of delivered doses within the body. The scanner has the potential to do so with high quantitative accuracy and fast scan times to be used for a routine application”, said Prof. Pierre-Yves Marie, MD, Ph.D., Head Department of Nuclear Medicine, University Hospital of Nancy, France. 

For more information: https://spectrum-dynamics.com/ 

Find more ASTRO22 content here


Related Content

News | Proton Therapy

November 25, 2022 — Researchers at the University of Wisconsin–Madison, the first U.S. clinical evaluation site for GE ...

Time November 25, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

November 21, 2022 — You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering ...

Time November 21, 2022
arrow
News | Radiopharmaceuticals and Tracers

November 15, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time November 15, 2022
arrow
Videos | ASTRO

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

Time November 09, 2022
arrow
News | Radiopharmaceuticals and Tracers

Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical ...

Time November 05, 2022
arrow
News | Proton Therapy

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
News | Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

Time November 02, 2022
arrow
Feature | ASTRO | Christine Book

November 2, 2022 — The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the ...

Time November 02, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during ...

Time November 01, 2022
arrow
Subscribe Now